SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-011954
Filing Date
2024-02-09
Accepted
2024-02-09 12:34:44
Documents
19
Period of Report
2024-02-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea193307-8k_inmedpharm.htm   iXBRL 8-K 45280
2 EMPLOYMENT AGREEMENT BY AND BETWEEN THE COMPANY AND NARINDER NETTA "NEETA" JAGPA ea193307ex10-1_inmedpharm.htm EX-10.1 333829
3 NEWS RELEASE, DATED FEBRUARY 9, 2024 ea193307ex99-1_inmedpharm.htm EX-99.1 11050
8 GRAPHIC ex10-1_001.jpg GRAPHIC 5773
9 GRAPHIC ex99-1_001.jpg GRAPHIC 5102
  Complete submission text file 0001213900-24-011954.txt   674064

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE inm-20240208.xsd EX-101.SCH 3265
5 XBRL DEFINITION FILE inm-20240208_def.xml EX-101.DEF 26195
6 XBRL LABEL FILE inm-20240208_lab.xml EX-101.LAB 35952
7 XBRL PRESENTATION FILE inm-20240208_pre.xml EX-101.PRE 24853
21 EXTRACTED XBRL INSTANCE DOCUMENT ea193307-8k_inmedpharm_htm.xml XML 4331
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 24613541
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)